Current status of PET imaging in neuro-oncology.

DOTATATE DOTATOC FDG FDOPA FET FLT MRI positron emission tomography

Journal

Neuro-oncology advances
ISSN: 2632-2498
Titre abrégé: Neurooncol Adv
Pays: England
ID NLM: 101755003

Informations de publication

Date de publication:
Historique:
entrez: 10 7 2020
pubmed: 28 5 2019
medline: 28 5 2019
Statut: epublish

Résumé

Over the past decades, a variety of PET tracers have been used for the evaluation of patients with brain tumors. For clinical routine, the most important clinical indications for PET imaging in patients with brain tumors are the identification of neoplastic tissue including the delineation of tumor extent for the further diagnostic and therapeutic management (ie, biopsy, resection, or radiotherapy planning), the assessment of response to a certain anticancer therapy including its (predictive) effect on the patients' outcome and the differentiation of treatment-related changes (eg, pseudoprogression and radiation necrosis) from tumor progression at follow-up. To serve medical professionals of all disciplines involved in the diagnosis and care of patients with brain tumors, this review summarizes the value of PET imaging for the latter-mentioned 3 clinically relevant indications in patients with glioma, meningioma, and brain metastases.

Identifiants

pubmed: 32642650
doi: 10.1093/noajnl/vdz010
pii: vdz010
pmc: PMC7324052
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

vdz010

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

Références

Eur J Nucl Med Mol Imaging. 2006 May;33(5):516-24
pubmed: 16450140
J Nucl Med. 2011 Jun;52(6):856-64
pubmed: 21622893
Clin Lung Cancer. 2019 Mar;20(2):e148-e151
pubmed: 30528316
J Neurooncol. 2013 Jan;111(1):11-8
pubmed: 23086431
J Nucl Med. 2014 Jan;55(1):30-6
pubmed: 24167081
Lancet Oncol. 2008 May;9(5):453-61
pubmed: 18452856
PLoS One. 2015 Jul 13;10(7):e0132515
pubmed: 26167681
J Neurooncol. 2008 Jun;88(2):205-10
pubmed: 18317691
J Neurosurg. 1985 Jan;62(1):18-24
pubmed: 3964853
J Nucl Med. 2007 Dec;48(12):2056-62
pubmed: 18006612
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):84-92
pubmed: 19662410
Case Rep Oncol. 2012 Sep;5(3):490-4
pubmed: 23271997
Neurosurgery. 2005 Sep;57(3):505-11; discussion 505-11
pubmed: 16145529
J Nucl Med. 2006 May;47(5):776-82
pubmed: 16644747
Handb Clin Neurol. 2018;149:113-121
pubmed: 29307348
Neuro Oncol. 2017 Feb 1;19(2):281-288
pubmed: 27471107
Radiat Oncol. 2011 May 15;6:48
pubmed: 21575163
Eur J Radiol. 2018 Jun;103:32-37
pubmed: 29803382
J Neurooncol. 2009 Oct;95(1):87-93
pubmed: 19381442
Neuro Oncol. 2014 Apr;16(4):603-9
pubmed: 24305722
Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):339-44
pubmed: 16765533
J Neurooncol. 2018 Sep;139(3):721-730
pubmed: 29948765
J Neuroimaging. 2003 Jul;13(3):269-71
pubmed: 12889176
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):591-602
pubmed: 30327856
J Nucl Med. 2004 Aug;45(8):1293-8
pubmed: 15299051
Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1409-15
pubmed: 22669255
Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1199-209
pubmed: 24604590
J Nucl Med. 2013 Feb;54(2):229-35
pubmed: 23232275
Neuro Oncol. 2019 May 6;21(5):585-595
pubmed: 30615138
Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):685-95
pubmed: 25411133
J Neurooncol. 2008 May;88(1):27-35
pubmed: 18217207
Neuro Oncol. 2016 Sep;18(9):1199-208
pubmed: 27106405
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):103-11
pubmed: 25182751
Lancet Neurol. 2010 Sep;9(9):906-20
pubmed: 20705518
J Nucl Med. 2017 Oct;58(10):1580-1587
pubmed: 28450556
Nat Rev Clin Oncol. 2009 Nov;6(11):648-57
pubmed: 19806145
Korean J Radiol. 2016 May-Jun;17(3):424-34
pubmed: 27134530
Orbit. 2015 Feb;34(1):16-22
pubmed: 25264824
Semin Nucl Med. 2012 Nov;42(6):356-70
pubmed: 23026359
J Nucl Med. 2012 Aug;53(8):1253-61
pubmed: 22743251
Neuro Oncol. 2016 Oct;18(10):1462-4
pubmed: 27591333
AJNR Am J Neuroradiol. 2014 Jun;35(6):1058-65
pubmed: 24029389
J Neurooncol. 2010 Sep;99(2):217-25
pubmed: 20091333
J Clin Oncol. 2007 Oct 20;25(30):4714-21
pubmed: 17947718
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):222-7
pubmed: 16488553
Mol Imaging. 2013 Jul-Aug;12(5):273-6
pubmed: 23759368
Lancet Oncol. 2018 Dec;19(12):1561-1563
pubmed: 30507413
PLoS One. 2016 Jun 08;11(6):e0157139
pubmed: 27276226
Front Neurol. 2016 Jul 28;7:120
pubmed: 27516754
Oncotarget. 2017 May 30;8(22):35743-35749
pubmed: 28415747
Neuro Oncol. 2011 Mar;13(3):307-16
pubmed: 21292686
Neuro Oncol. 2017 Nov 29;19(12):1576-1587
pubmed: 28605532
J Clin Oncol. 1990 Jul;8(7):1277-80
pubmed: 2358840
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2377-2386
pubmed: 29982845
Q J Nucl Med Mol Imaging. 2018 Sep;62(3):272-280
pubmed: 29869488
J Nucl Med. 2012 Jul;53(7):1048-57
pubmed: 22645298
Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1464-70
pubmed: 15248032
Neuroimage Clin. 2018 Aug 19;20:537-542
pubmed: 30175040
Clin Cancer Res. 2014 Jul 1;20(13):3550-9
pubmed: 24687922
Neuro Oncol. 2013 Mar;15(3):341-51
pubmed: 23335162
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557
pubmed: 30519867
Minim Invasive Neurosurg. 2005 Aug;48(4):228-34
pubmed: 16172969
AJNR Am J Neuroradiol. 2017 Aug;38(8):1520-1527
pubmed: 28619837
J Nucl Med. 2012 Apr;53(4):552-8
pubmed: 22419752
Clin Cancer Res. 2004 Nov 1;10(21):7163-70
pubmed: 15534088
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1432-43
pubmed: 26819102
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):310-8
pubmed: 19763565
J Nucl Med. 2001 Jul;42(7):1053-6
pubmed: 11438627
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1021-9
pubmed: 22491781
J Clin Oncol. 2013 Jan 1;31(1):e1-5
pubmed: 23169514
Acta Neuropathol. 2015 Sep;130(3):441-3
pubmed: 26195322
Front Oncol. 2018 Feb 22;8:18
pubmed: 29520339
J Nucl Med. 2005 Dec;46(12):1948-58
pubmed: 16330557
J Nucl Med. 2008 May;49(5):694-9
pubmed: 18413375
Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1089-96
pubmed: 22419257
AJNR Am J Neuroradiol. 2013 May;34(5):944-50, S1-11
pubmed: 23124638
Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1521-8
pubmed: 20396883
Radiology. 1995 Apr;195(1):47-52
pubmed: 7892494
AJNR Am J Neuroradiol. 2015 Dec;36(12):2250-5
pubmed: 26427832
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1161-7
pubmed: 18440729
J Neurosurg. 2003 May;98(5):1056-64
pubmed: 12744366
J Nucl Med. 2015 Mar;56(3):347-53
pubmed: 25635133
J Clin Endocrinol Metab. 1986 Aug;63(2):433-8
pubmed: 3013920
J Nucl Med. 2005 Mar;46(3):411-6
pubmed: 15750152
AJNR Am J Neuroradiol. 2011 Dec;32(11):1978-85
pubmed: 21393407
Future Oncol. 2014 Nov;10(14):2259-77
pubmed: 25471038
J Nucl Med. 2012 Feb;53(2):207-14
pubmed: 22302961
Neuro Oncol. 2016 Jun;18(6):873-80
pubmed: 26688076
Q J Nucl Med Mol Imaging. 2018 Sep;62(3):239-253
pubmed: 29696946
Int J Cancer. 2001 Jun 20;96(3):191-7
pubmed: 11410888
J Nucl Med. 2013 Aug;54(8):1217-22
pubmed: 23785172
Mol Imaging. 2010 Feb;9(1):40-6
pubmed: 20128997
Neuro Oncol. 2016 Nov;18(11):1538-1547
pubmed: 27106404
Radiology. 2000 Nov;217(2):377-84
pubmed: 11058631
Clin Nucl Med. 2016 May;41(5):e228-36
pubmed: 26859208
J Nucl Med. 2017 Apr;58(4):584-589
pubmed: 27754904
J Nucl Med. 2012 Sep;53(9):1367-74
pubmed: 22872742
Clin Neurol Neurosurg. 2013 Feb;115(2):165-9
pubmed: 22652237
Clin Nucl Med. 2014 Apr;39(4):e283-5
pubmed: 24566411
Nat Rev Neurol. 2017 May;13(5):279-289
pubmed: 28387340
Neuro Oncol. 2015 Sep;17(9):1293-300
pubmed: 26008606
Cancers (Basel). 2019 Jan 29;11(2):
pubmed: 30699942
Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):22-33
pubmed: 23053325
Expert Rev Anticancer Ther. 2011 May;11(5):653-6
pubmed: 21554035
Eur J Nucl Med. 2000 Dec;27(12):1793-9
pubmed: 11189942
Neuro Oncol. 2015 Nov;17(11):1434-44
pubmed: 26130743
Radiat Oncol. 2016 Oct 21;11(1):139
pubmed: 27769279
J Clin Oncol. 2010 Apr 10;28(11):1963-72
pubmed: 20231676
J Nucl Med. 2017 Jan;58(1):129-137
pubmed: 27469356
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):68-73
pubmed: 22575489
Nat Med. 1998 Nov;4(11):1334-6
pubmed: 9809561
Neuro Oncol. 2016 May;18(5):744-51
pubmed: 26578622
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):176-84
pubmed: 20646863
Methods. 2017 Nov 1;130:124-134
pubmed: 28552264
Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):96-100
pubmed: 12483415
J Nucl Med. 2007 May;48(5):720-5
pubmed: 17475959
Int J Cancer. 1998 May 29;76(5):620-7
pubmed: 9610716
Radiat Oncol. 2009 Nov 18;4:56
pubmed: 19922642
Nat Rev Neurol. 2016 Jul;12(7):375-6
pubmed: 27282652
Brain. 2005 Mar;128(Pt 3):678-87
pubmed: 15689365
Hum Pathol. 2002 Dec;33(12):1211-26
pubmed: 12514791
Neuro Oncol. 2017 Sep 1;19(9):1271-1278
pubmed: 28204572
J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):238-239
pubmed: 29705720

Auteurs

Norbert Galldiks (N)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.
Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.
Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.

Philipp Lohmann (P)

Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.

Nathalie L Albert (NL)

Department of Nuclear Medicine, Ludwig Maximilians-University of Munich, Munich, Germany.

Jörg C Tonn (JC)

Department of Neurosurgery, Ludwig Maximilians-University of Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, Germany.

Karl-Josef Langen (KJ)

Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany.

Classifications MeSH